IQVIA Hldgs's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on IQVIA Hldgs IQV.

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with IQV, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 10 options trades for IQVIA Hldgs.

This isn't normal.

The overall sentiment of these big-money traders is split between 100% bullish and 0%, bearish.

Out of all of the options we uncovered, 9 are puts, for a total amount of $369,729, and there was 1 call, for a total amount of $30,600.

Expected Price Movements

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $240.0 and $290.0 for IQVIA Hldgs, spanning the last three months.

Analyzing Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in IQVIA Hldgs's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to IQVIA Hldgs's substantial trades, within a strike price spectrum from $240.0 to $290.0 over the preceding 30 days.

IQVIA Hldgs Option Activity Analysis: Last 30 Days

Noteworthy Options Activity:

About IQVIA Hldgs

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

After a thorough review of the options trading surrounding IQVIA Hldgs, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Present Market Standing of IQVIA Hldgs

• Trading volume stands at 109,346, with IQV's price down by 0.0%, positioned at $255.65.
• RSI indicators show the stock to be may be approaching overbought.
• Earnings announcement expected in 42 days.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IQVIA Hldgs options trades with real-time alerts from Benzinga Pro.